105 related articles for article (PubMed ID: 15725387)
1. Macrophages at intermediate stage of maturation produce high levels of IL-12 p40 upon stimulation with Leishmania.
Oliveira MA; Tadokoro CE; Lima GM; Mosca T; Vieira LQ; Leenen PJ; Abrahamsohn IA
Microbes Infect; 2005 Feb; 7(2):213-23. PubMed ID: 15725387
[TBL] [Abstract][Full Text] [Related]
2. Immature macrophages derived from mouse bone marrow produce large amounts of IL-12p40 after LPS stimulation.
Oliveira MA; Lima GM; Shio MT; Leenen PJ; Abrahamsohn IA
J Leukoc Biol; 2003 Nov; 74(5):857-67. PubMed ID: 14595006
[TBL] [Abstract][Full Text] [Related]
3. PKCδ regulates IL-12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis.
Guler R; Afshar M; Arendse B; Parihar SP; Revaz-Breton M; Leitges M; Schwegmann A; Brombacher F
Eur J Immunol; 2011 Mar; 41(3):706-15. PubMed ID: 21287553
[TBL] [Abstract][Full Text] [Related]
4. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.
Carrera L; Gazzinelli RT; Badolato R; Hieny S; Muller W; Kuhn R; Sacks DL
J Exp Med; 1996 Feb; 183(2):515-26. PubMed ID: 8627163
[TBL] [Abstract][Full Text] [Related]
5. CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing.
Vanloubbeeck YF; Ramer AE; Jie F; Jones DE
Infect Immun; 2004 Aug; 72(8):4455-63. PubMed ID: 15271903
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-3Ralpha+ myeloid dendritic cells and mast cells develop simultaneously from different bone marrow precursors in cultures with interleukin-3.
Baumeister T; Rössner S; Pech G; de Bruijn MF; Leenen PJ; Schuler G; Lutz MB
J Invest Dermatol; 2003 Aug; 121(2):280-8. PubMed ID: 12880419
[TBL] [Abstract][Full Text] [Related]
8. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
[TBL] [Abstract][Full Text] [Related]
9. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
Prina E; Lang T; Glaichenhaus N; Antoine JC
J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
[TBL] [Abstract][Full Text] [Related]
10. Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens.
Leenen PJ; Melis M; Slieker WA; Van Ewijk W
Eur J Immunol; 1990 Jan; 20(1):27-34. PubMed ID: 2407538
[TBL] [Abstract][Full Text] [Related]
11. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro phagocytosis of Leishmania (Leishmania) amazonensis promastigotes by B-1 cells.
Geraldo MM; Costa CR; Barbosa FM; Vivanco BC; Gonzaga WF; Novaes E Brito RR; Popi AF; Lopes JD; Xander P
Parasite Immunol; 2016 Jun; 38(6):365-76. PubMed ID: 27084328
[TBL] [Abstract][Full Text] [Related]
13. High dilutions of antimony modulate cytokines production and macrophage - Leishmania (L.) amazonensis interaction in vitro.
de Santana FR; Dalboni LC; Nascimento KF; Konno FT; Alvares-Saraiva AM; Correia MSF; Bomfim MDC; Casarin RCV; Perez EC; Lallo MA; Peres GB; Laurenti MD; Benites NR; Buchi DF; Bonamin LV
Cytokine; 2017 Apr; 92():33-47. PubMed ID: 28092793
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD
Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo.
Xin L; Li Y; Soong L
Infect Immun; 2007 Oct; 75(10):5018-26. PubMed ID: 17682041
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro.
Bersudsky M; Apte RN; El-On J
Exp Parasitol; 2000 Mar; 94(3):150-7. PubMed ID: 10831379
[TBL] [Abstract][Full Text] [Related]
17. IL-18 contributes to susceptibility to Leishmania amazonensis infection by macrophage-independent mechanisms.
Sousa LM; Carneiro MB; Dos Santos LM; Natale CC; Resende ME; Mosser DM; Vieira LQ
Cytokine; 2015 Aug; 74(2):327-30. PubMed ID: 26009021
[TBL] [Abstract][Full Text] [Related]
18. Monocyte and macrophage functions in M-CSF-deficient op/op mice during experimental leishmaniasis.
Schönlau F; Schlesiger C; Ehrchen J; Grabbe S; Sorg C; Sunderkötter C; Ehrehen J
J Leukoc Biol; 2003 May; 73(5):564-73. PubMed ID: 12714570
[TBL] [Abstract][Full Text] [Related]
19. Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages.
Avni D; Goldsmith M; Ernst O; Mashiach R; Tuntland T; Meijler MM; Gray NS; Rosen H; Zor T
Immunol Lett; 2009 Mar; 123(1):1-8. PubMed ID: 19185589
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T cells are not required for vaccine-induced immunity against Leishmania amazonensis in IL-12/23P40(-/-) C57BL/6 mice.
Hernández Sanabria MX; Afonso LC; Golgher D; Tafuri WL; Vieira LQ
Microbes Infect; 2007 Jul; 9(9):1124-34. PubMed ID: 17662634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
